| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 19 | / | 2014 | ||||||||
| Date of issue: | 2014-02-12 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 19 UPF Doverie 4.155% 12022014 ENG | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 70 pkt 1 Ustawy o ofercie - nabycie lub zbycie znacznego pakietu akcji | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") announces that on 11 February 2014 the Company received a notification for the sale of 3 424 005 shares by UPF Doverie. After the transaction the share of UPF Doverie in the capital of Sopharma AD decreased to 4,155 %. The registration date of the transaction in the Central Depository AD, Sofia is 6 February 2014. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 19 UPF Doverie 4.155% 12022014 ENG.doc | Current report 19 UPF Doverie 4.155% 12022014 ENG | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2014-02-12 | Ognian Donev | Executive director | |||
